75/100B47.010
USD
0.10
(0.21%)
Pre Open·48.030USD+1.020(+2.17%)
Last updated: · Delayed 15 min
Fair value82.55Plus-43%62Price 47.01103
Q4 FY2026 · Earnings report
EPS estimate 0.96Revenue estimate 14.41B
Q4 FY2026 · Earnings report
EPS estimate 0.96Revenue estimate 14.41B
Sanofi ADS revenue 1999–2026What is revenue? Revenue is the money a company brings in from selling its goods and services over a period, before any costs. It is the top line of the income statement.
Sanofi ADS's revenue in Q3 FY2026, the three months to 30 September 2026, was 15.23B EUR, up 15.7% on the same quarter a year before. Sanofi ADS's revenue over the last twelve months was 50.98B EUR, up 21.0% on the twelve months before. In fiscal year 2025 it was 46.72B EUR, up 5.5% on the year before.
Last updated 9 Nov 2026 · Next report 4 Feb 2027
Revenue
Growth
| Fiscal year | Period ending | Revenue | Growth | Gross profit | Net income |
|---|---|---|---|---|---|
| TTM | 30 Sept 2026 | 50.98B | +20.98% | 37.57B | 4.18B |
| FY2025 | 31 Dec 2025 | 46.72B | +5.49% | 33.67B | 7.81B |
| FY2024 | 31 Dec 2024 | 44.29B | +6.41% | 31.08B | 5.56B |
| FY2023 | 31 Dec 2023 | 41.62B | +2.61% | 28.99B | 5.40B |
| FY2022 | 31 Dec 2022 | 40.56B | +3.54% | 28.68B | 8.37B |
| FY2021 | 31 Dec 2021 | 39.18B | +4.83% | 26.92B | 6.22B |
| FY2020 | 31 Dec 2020 | 37.37B | -0.70% | 25.21B | 12.29B |
| FY2019 | 31 Dec 2019 | 37.63B | +5.48% | 25.65B | 2.75B |
| FY2018 | 31 Dec 2018 | 35.68B | -1.50% | 24.24B | 4.31B |
| FY2017 | 31 Dec 2017 | 36.22B | +4.40% | 24.61B | 8.42B |
| FY2016 | 31 Dec 2016 | 34.70B | -0.47% | 24.00B | 4.71B |
| FY2015 | 31 Dec 2015 | 34.86B | +8.94% | 23.94B | 4.29B |
| FY2014 | 31 Dec 2014 | 32.00B | +2.26% | 21.77B | 4.39B |
| FY2013 | 31 Dec 2013 | 31.29B | -12.98% | 20.99B | 3.72B |
| FY2012 | 31 Dec 2012 | 35.96B | +2.56% | 24.86B | 4.89B |
| FY2011 | 31 Dec 2011 | 35.06B | +3.00% | 24.19B | 5.65B |
| FY2010 | 31 Dec 2010 | 34.04B | +10.69% | 24.64B | 5.47B |
| FY2009 | 31 Dec 2009 | 30.75B | +6.70% | 22.87B | 5.27B |
| FY2008 | 31 Dec 2008 | 28.82B | -1.34% | 21.48B | 3.85B |
| FY2007 | 31 Dec 2007 | 29.21B | -0.96% | 21.64B | 5.26B |
| FY2006 | 31 Dec 2006 | 29.49B | +3.50% | 21.90B | 4.01B |
| FY2005 | 31 Dec 2005 | 28.49B | +81.23% | 20.93B | 2.26B |
| FY2004 | 31 Dec 2004 | 15.72B | +95.69% | 11.29B | 1.98B |
| FY2003 | 31 Dec 2003 | 8.03B | +7.77% | 6.61B | 2.07B |
| FY2002 | 31 Dec 2002 | 7.46B | +14.91% | 6.08B | 1.76B |
| FY2001 | 31 Dec 2001 | 6.49B | +8.80% | 5.24B | 1.59B |
| FY2000 | 31 Dec 2000 | 5.96B | +11.46% | 4.52B | 985.00M |
| FY1999 | 31 Dec 1999 | 5.35B | — | 3.74B | 625.00M |
| Quarter | Period ending | Revenue | Growth on a year before | Gross profit | Net income |
|---|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 15.23B | +15.66% | 11.60B | 3.02B |
| Q2 FY2026 | 30 Jun 2026 | 12.30B | +14.58% | 9.28B | 343.00M |
| Q1 FY2026 | 31 Mar 2026 | 11.24B | +6.02% | 8.11B | 1.61B |
| Q4 FY2025 | 31 Dec 2025 | 12.21B | +59.94% | 8.58B | -801.00M |
| Q3 FY2025 | 30 Sept 2025 | 13.17B | -6.97% | 9.76B | 2.80B |
| Q2 FY2025 | 30 Jun 2025 | 10.74B | -5.67% | 7.74B | 3.94B |
| Q1 FY2025 | 31 Mar 2025 | 10.61B | +9.05% | 7.72B | 1.87B |
| Q4 FY2024 | 31 Dec 2024 | 7.63B | -37.46% | 5.36B | 499.00M |
| Q3 FY2024 | 30 Sept 2024 | 14.16B | +11.49% | 10.07B | 2.82B |
| Q2 FY2024 | 30 Jun 2024 | 11.38B | +6.53% | 7.97B | 1.11B |
| Q1 FY2024 | 31 Mar 2024 | 9.73B | -10.47% | 6.76B | 1.13B |
| Q4 FY2023 | 31 Dec 2023 | 12.20B | +6.50% | 8.15B | -555.00M |
| Q3 FY2023 | 30 Sept 2023 | 12.70B | -3.35% | 8.86B | 2.53B |
| Q2 FY2023 | 30 Jun 2023 | 10.68B | -0.56% | 7.41B | 1.44B |
| Q1 FY2023 | 31 Mar 2023 | 10.86B | +8.06% | 7.78B | 2.00B |
| Q4 FY2022 | 31 Dec 2022 | 11.46B | +10.00% | 7.72B | 3.11B |
| Q3 FY2022 | 30 Sept 2022 | 13.14B | +21.32% | 9.31B | 2.08B |
| Q2 FY2022 | 30 Jun 2022 | 10.74B | +18.76% | 7.49B | 1.18B |
| Q1 FY2022 | 31 Mar 2022 | 10.05B | +13.13% | 7.17B | 2.01B |
| Q4 FY2021 | 31 Dec 2021 | 10.42B | +6.97% | 6.94B | 1.13B |
| Q3 FY2021 | 30 Sept 2021 | 10.83B | +9.62% | 7.59B | 2.31B |
| Q2 FY2021 | 30 Jun 2021 | 9.05B | +7.19% | 6.19B | 1.21B |
| Q1 FY2021 | 31 Mar 2021 | 8.89B | -4.62% | 6.20B | 1.57B |
| Q4 FY2020 | 31 Dec 2020 | 9.74B | -2.81% | 6.30B | 1.06B |
| Q3 FY2020 | 30 Sept 2020 | 9.88B | -0.42% | 6.70B | 1.95B |
| Q2 FY2020 | 30 Jun 2020 | 8.44B | -6.04% | 5.76B | 7.60B |
| Q1 FY2020 | 31 Mar 2020 | 9.32B | +6.92% | 6.45B | 1.68B |
| Q4 FY2019 | 31 Dec 2019 | 10.02B | +7.41% | 6.56B | -10.00M |
| Q3 FY2019 | 30 Sept 2019 | 9.92B | +1.82% | 6.79B | 1.77B |
| Q2 FY2019 | 30 Jun 2019 | 8.98B | +5.88% | 6.21B | -87.00M |
| Q1 FY2019 | 31 Mar 2019 | 8.71B | +7.22% | 6.10B | 1.14B |
| Q4 FY2018 | 31 Dec 2018 | 9.33B | +3.84% | 6.19B | 254.00M |
| Q3 FY2018 | 30 Sept 2018 | 9.74B | +3.74% | 6.71B | 2.27B |
| Q2 FY2018 | 30 Jun 2018 | 8.48B | -5.06% | 5.76B | 762.00M |
| Q1 FY2018 | 31 Mar 2018 | 8.13B | -8.67% | 5.58B | 1.02B |
| Q4 FY2017 | 31 Dec 2017 | 8.98B | -2.14% | 5.89B | 129.00M |
| Q3 FY2017 | 30 Sept 2017 | 9.39B | +1.05% | 6.54B | 1.57B |
| Q2 FY2017 | 30 Jun 2017 | 8.93B | +7.52% | 6.05B | 1.04B |
| Q1 FY2017 | 31 Mar 2017 | 8.90B | +12.22% | 6.11B | 5.70B |
| Q4 FY2016 | 31 Dec 2016 | 9.18B | +34.36% | 6.22B | 790.00M |
| Q3 FY2016 | 30 Sept 2016 | 9.30B | -3.98% | 6.52B | 1.67B |
| Q2 FY2016 | 30 Jun 2016 | 8.31B | -5.18% | 5.79B | 1.16B |
| Q1 FY2016 | 31 Mar 2016 | 7.93B | -3.55% | 5.48B | 1.09B |
| Q4 FY2015 | 31 Dec 2015 | 6.83B | -25.52% | 4.63B | 334.00M |
| Q3 FY2015 | 30 Sept 2015 | 9.68B | +9.16% | 6.68B | 1.63B |
| Q2 FY2015 | 30 Jun 2015 | 8.76B | +7.56% | 6.06B | 1.30B |
| Q1 FY2015 | 31 Mar 2015 | 8.22B | +3.72% | 5.65B | 1.02B |
| Q4 FY2014 | 31 Dec 2014 | 9.17B | +7.31% | 6.13B | 1.34B |
| Q3 FY2014 | 30 Sept 2014 | 8.87B | +4.11% | 6.00B | 1.19B |
| Q2 FY2014 | 30 Jun 2014 | 8.15B | +0.74% | 5.54B | 777.00M |
| Q1 FY2014 | 31 Mar 2014 | 7.93B | -2.84% | 5.41B | 1.08B |
| Q4 FY2013 | 31 Dec 2013 | 8.55B | -1.36% | 5.64B | 1.06B |
| Q3 FY2013 | 30 Sept 2013 | 8.52B | -7.81% | 5.65B | 1.22B |
| Q2 FY2013 | 30 Jun 2013 | 8.09B | -11.31% | 5.41B | 448.00M |
| Q1 FY2013 | 31 Mar 2013 | 8.16B | -8.73% | 5.61B | 989.00M |
| Q4 FY2012 | 31 Dec 2012 | 8.66B | -2.91% | 5.79B | 410.00M |
| Q3 FY2012 | 30 Sept 2012 | 9.24B | +0.74% | 6.36B | 1.54B |
| Q2 FY2012 | 30 Jun 2012 | 9.12B | +3.94% | 6.39B | 1.15B |
| Q1 FY2012 | 31 Mar 2012 | 8.94B | +9.09% | 6.32B | 1.81B |
| Q4 FY2011 | 31 Dec 2011 | 8.92B | +14.25% | 6.13B | 1.44B |
| Q3 FY2011 | 30 Sept 2011 | 9.17B | +11.05% | 6.28B | 2.03B |
| Q2 FY2011 | 30 Jun 2011 | 8.77B | +7.08% | 5.92B | 1.01B |
| Q1 FY2011 | 31 Mar 2011 | 8.19B | +5.36% | 5.83B | 1.22B |
| Q4 FY2010 | 31 Dec 2010 | 7.81B | +1.05% | 5.49B | 437.00M |
| Q3 FY2010 | 30 Sept 2010 | 8.26B | +6.27% | 5.96B | 1.61B |
| Q2 FY2010 | 30 Jun 2010 | 8.19B | +5.05% | 6.12B | 1.71B |
| Q1 FY2010 | 31 Mar 2010 | 7.78B | +4.35% | 5.74B | 1.71B |
| Q4 FY2009 | 31 Dec 2009 | 7.73B | +3.66% | 5.50B | 1.21B |
| Q3 FY2009 | 30 Sept 2009 | 7.77B | +8.47% | 5.74B | 1.42B |
| Q2 FY2009 | 30 Jun 2009 | 7.80B | +9.75% | 5.95B | 1.06B |
| Q1 FY2009 | 31 Mar 2009 | 7.45B | +5.03% | 5.68B | 1.58B |
| Q4 FY2008 | 31 Dec 2008 | 7.46B | -8.67% | 5.53B | -1.06B |
| Q3 FY2008 | 30 Sept 2008 | 7.17B | +2.80% | 5.37B | 1.89B |
| Q2 FY2008 | 30 Jun 2008 | 7.10B | -3.09% | 5.30B | 1.17B |
| Q1 FY2008 | 31 Mar 2008 | 7.09B | +0.54% | 7.09B | 1.17B |
| Q4 FY2007 | 31 Dec 2007 | 8.16B | +10.52% | 8.16B | 1.31B |
| Q3 FY2007 | 30 Sept 2007 | 6.97B | -5.24% | 6.97B | 1.30B |
| Q2 FY2007 | 30 Jun 2007 | 7.33B | -1.52% | 5.48B | 1.33B |
| Q1 FY2007 | 31 Mar 2007 | 7.06B | -3.61% | 7.06B | 1.33B |
| Q4 FY2006 | 31 Dec 2006 | 7.39B | +0.57% | 7.39B | 815.46M |
| Q3 FY2006 | 30 Sept 2006 | 7.36B | -2.05% | 7.36B | 811.60M |
| Q2 FY2006 | 30 Jun 2006 | 7.44B | +9.27% | 5.55B | 869.47M |
| Q1 FY2006 | 31 Mar 2006 | 7.32B | +9.96% | 5.45B | 1.51B |
| Q4 FY2005 | 31 Dec 2005 | 7.34B | +37.89% | 5.44B | 455.64M |
| Q3 FY2005 | 30 Sept 2005 | 7.51B | +40.77% | 5.54B | 713.99M |
| Q2 FY2005 | 30 Jun 2005 | 6.81B | +189.12% | 4.97B | 542.64M |
| Q1 FY2005 | 31 Mar 2005 | 6.66B | +198.92% | 4.96B | 1.41B |
| Q4 FY2004 | 31 Dec 2004 | 5.33B | +200.62% | 5.33B | -2.36B |
| Q3 FY2004 | 30 Sept 2004 | 5.33B | +120.69% | 5.33B | -2.36B |
| Q2 FY2004 | 30 Jun 2004 | 2.36B | +20.98% | 1.83B | 556.67M |
| Q1 FY2004 | 31 Mar 2004 | 2.23B | +14.46% | 2.23B | 568.16M |
| Q4 FY2003 | 31 Dec 2003 | 1.77B | -6.13% | 1.77B | 487.97M |
| Q3 FY2003 | 30 Sept 2003 | 2.42B | +29.18% | 2.42B | 654.54M |
| Q2 FY2003 | 30 Jun 2003 | 1.95B | +6.02% | 1.57B | 471.06M |
| Q1 FY2003 | 31 Mar 2003 | 1.95B | — | 1.95B | 470.44M |
| Q4 FY2002 | 31 Dec 2002 | 1.89B | — | 1.89B | 464.94M |
| Q3 FY2002 | 30 Sept 2002 | 1.87B | — | 1.87B | 461.77M |
| Q2 FY2002 | 30 Jun 2002 | 1.84B | — | 1.48B | 414.72M |
Figures in EUR. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.
Sanofi ADS revenue by segment over time
See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement
Common questions about Sanofi ADS's revenue
Source: Financial Modeling Prep